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Human rhinoviruses (HRVs) frequently cause mild upper respiratory tract infections and more
severe disease manifestations such as bronchiolitis and asthma exacerbations. HRV is classified
into three species within the genus Enterovirus of the family Picornaviridae. HRV species A and B
contain 75 and 25 serotypes identified by cross-neutralization assays, although the use of such
assays for routine HRV typing is hampered by the large number of serotypes, replacement of virus
isolation by molecular methods in HRV diagnosis and the poor or absent replication of HRV
species C in cell culture. To address these problems, we propose an alternative, genotypic
classification of HRV-based genetic relatedness analogous to that used for enteroviruses.
Nucleotide distances between 384 complete VP1 sequences of currently assigned HRV
(sero)types identified divergence thresholds of 13, 12 and 13% for species A, B and C,
respectively, that divided inter- and intra-type comparisons. These were paralleled by 10, 9.5 and
10% thresholds in the larger dataset of .3800 VP4 region sequences. Assignments based on
VP1 sequences led to minor revisions of existing type designations (such as the reclassification of
serotype pairs, e.g. A8/A95 and A29/A44, as single serotypes) and the designation of new HRV
types A101–106, B101–103 and C34–C51. A protocol for assignment and numbering of new
HRV types using VP1 sequences and the restriction of VP4 sequence comparisons to type
identification and provisional type assignments is proposed. Genotypic assignment and
identification of HRV types will be of considerable value in the future investigation of type-
associated differences in disease outcomes, transmission and epidemiology.
INTRODUCTION
Human rhinoviruses (HRVs) are highly prevalent respir-
atory pathogens traditionally associated with mild and self-
limited upper respiratory tract infections (‘colds’). The
replacement of relatively insensitive virus isolation methods
with molecular methods for HRV detection has contributed
to a recent reappraisal of their incidence of infection and
genetic diversity. HRVs are now known to be intimately
linked to the development and exacerbations of respiratory
diseases such as asthma (Khetsuriani et al., 2008; Miller et al.,
2007) and responsible for more severe disease manifestations
such as bronchiolitis in young children and in the
immunosuppressed (Gutman et al., 2007; Ison et al., 2003;
McErlean et al., 2007). Genetic characterization of HRVs
detected by molecular methods has revealed much greater
diversity than previously described; approximately one-third
of HRV infections are now known to be caused by a third
group of rhinoviruses (species C), uncultureable in vitro and
therefore entirely missed by traditional virus isolation
methods (Arden et al., 2006; Kaiser et al., 2006; Kistler
et al., 2007a; Lamson et al., 2006; Lau et al., 2007; Lee et al.,
2007; McErlean et al., 2007; Olenec et al., 2010; Renwick
et al., 2007).
HRVs are members of the genus Enterovirus of the family
Picornaviridae, a large virus group that additionally contains
human enteroviruses and a number of viruses infecting non-
human primates, pigs, cattle, sheep and other mammals
(Knowles et al., 2012). The genus Enterovirus has recently
been divided into a total of 12 species based on their genetic
divergence, sites of replication and disease associations
(http://www.picornaviridae.com). Among these species,
three are designated Rhinovirus A, Rhinovirus B and
Rhinovirus C, a nomenclature that reflects their primary
tropism for the respiratory tract. Currently, humans are
the only known natural host, although it is possible
that primates could also be susceptible. Rhinovirus B and
most Rhinovirus A variants use the intracellular adhesion
The GenBank/EMBL/DDBJ accession numbers for the sequences
determined in this study are KC342054–KC342104.
Four supplementary tables are available with the online version of this
paper.
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molecule-1 (major) receptor for cell entry (Uncapher et al.,
1991), whilst a subset of Rhinovirus A types use the low-
density lipoprotein receptor (Hofer et al., 1994). The
receptor(s) used by HRV species C (HRV-C) types is
currently unknown. HRVs are most commonly transmitted
by the respiratory–salivary route, both by person-to-person
contact and by airborne transmission. In temperate
countries, infections occur primarily in two peaks, the first
between April and May and the second between September
and October (Monto, 2002; Vesa et al., 2001).
HRVs within each species show remarkable genetic and,
where determined, antigenic heterogeneity. Species A and
B isolates were originally characterized serologically, with
75 and 25 serotypes being classified by cross-neutralization
assays by 1987 (Hamparian et al., 1987; Kapikian et al.,
1967, 1971), and prototype strains of each were lodged at
the American Type Culture Collection (ATCC). However,
as well as being laborious, time-consuming and requiring
extensive panels of antisera specific to each serotype,
classification by neutralization cannot be used for species C
rhinoviruses because of their refractoriness to cell culture.
Human enteroviruses (EVs) are classified into four species
(Enterovirus A, Enterovirus B, Enterovirus C and Enterovirus
D) and, like HRVs, isolates have also been traditionally
characterized by neutralization assays. Some neutralization
determinants are located on the external VP1 protein in the
virus nucleocapsid, and it has been shown that sequence
divergence in this region correlates with serotype designation
of poliovirus isolates (Kilpatrick et al., 1998) and other
enteroviruses (Kiang et al., 2009; Oberste et al., 1999a, b).
Indeed, a threshold of 25% nucleotide and 12% amino acid
sequence divergence generally corresponds to the previous
serological division of EVs into members of the same or
different serotypes (Oberste et al., 1999a). As well as
providing a simpler method for EV type identification than
the previously used serological assays, VP1 sequencing is now
routinely used for identification and assignment of new EV
types without serological confirmation of antigenic differ-
ences (Brown et al., 2009; Oberste et al., 2002, 2004, 2007).
In the current study, we investigated whether a comparable
threshold of sequence diversity in the VP1 of HRVs would
enable a similar genotypic division of HRV-A, -B and -C
variants into types and additionally whether this correlated
with sequence divergence in the VP4/VP2 region (routinely
used for HRV typing). This investigation was prompted by
the increasing use of molecular methods to characterize
HRVs and the consequent lack of isolates or antisera with
which to antigenically characterize them and, secondly, by
the difficulty in culturing species C HRVs required for
neutralization assays (Bochkov et al., 2011; Kistler et al.,
2007a; McErlean et al., 2007).
This investigation follows on from previously published
proposals for the classification of HRV-C based on a 13%
divergence threshold in VP1 (Simmonds et al., 2010).
These have been adopted by the Picornaviridae Study
Group as the primary mechanism for defining HRV-C
types. We have extended this classification system for
species A and B rhinoviruses. The previously used term
‘serotype’ reflects the identification and classification of
HRV variants by antigenic properties and therefore
assignment by genetic comparison methods requires a
different or combined term. Following the terminology
now used for enteroviruses, we have adopted the term
‘type’ throughout the study to represent those HRV
variants that have been identified and classified by either
cross-neutralization or genetic comparisons.
RESULTS
Assigning nucleotide divergence thresholds in the
VP1 region of HRV-A, -B and -C
In order to determine whether a distinct threshold that
divided pairwise p-distance comparisons in the VP1 region
into intra- and inter-type values existed within each HRV
species, distributions of pairwise nucleotide p-distances
were constructed from a total of 435 HRV-A, 133 HRV-B
and 206 HRV-C VP1 sequences (Fig. 1; sequences used for
species C represent an expanded dataset from the one
analysed previously; Simmonds et al., 2010). These showed
a maximum within-species nucleotide p-distance of 39.4,
33.9 and 42.9% for species A, B and C, respectively, and
minimum values of between 10 and 14% divergence.
Detailed inspection allowed identification of minimum
values in the distribution and assignment of a nucleotide
divergence threshold for each species (Fig. 1, right-hand
panels). A threshold of 13% was identified for both HRV-
A and -C sequences, whilst the less-divergent HRV-B
isolates showed a minimum value that supported a 12%
threshold.
The total datasets of available VP1 sequences contained
unequal representations of different types within each
species, ranging from one to a maximum of 13 for HRV-A
(A49), 10 for HRV-B (B69) and 22 for HRV-C (C3).
Particularly for pairwise distance comparisons, these may
potentially distort the shape of the distribution of inter-type
distances because comparisons with certain types are over-
represented in the distance totals. An additional analysis was
therefore carried out with only single sequences from each
type (grey shading superimposed in Fig. 1, left graphs). For
each, prototype strains of HRV-A and -B were those of the
first full-genome sequence of a deposited ATCC isolate that
was deposited in GenBank (highlighted in red in Table S1 in
JGV Online). Prototype strains of HRV-C were those listed
previously (Simmonds et al., 2010; Table S1). This closely
reproduced the analysis of the whole VP1 dataset in the
shape and range of the inter-type distribution of distances
(Fig. 1). Whilst distance distributions between VP1
sequences of HRV-A and -C showed a single peak, those
of HRV-B showed a bimodal distribution. The peak between
p-distance values of 0.19 and 0.26 corresponded to
comparisons between HRV-B types within each of the
four basally branching phylogenetic clusters (indicated by
C. L. McIntyre, N. J. Knowles and P. Simmonds
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grey-outlined boxes in Fig. 2). The larger peak thus
corresponded to comparisons between variants in different
clusters.
Phylogenetic analysis of the VP1 region
Phylogenetic trees were constructed of the VP1 region of
HRV-A, -B and -C (Fig. 2). All HRV sequences fell into
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Fig. 1. Distributions of pairwise nucleotide p-distances for the VP1 region of HRV-A (a), -B (b) and -C (c). Left graphs show
number of sequences of the pairwise distances between all available VP1 sequences in black (left y-axis) and a comparison of
prototype strains only in grey (right y-axis). The proposed thresholds for type assignment are shown as dotted lines. Right
graphs show the sequences distances around the proposed assignment thresholds for each species shown using an expanded
x-axis scale.
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Fig. 2. Neighbour-joining phylogenetic trees showing the VP1 region of HRV-A, -B and -C. The tree was constructed from by a
neighbour-joining method from 100 bootstrap resampled sequence alignments of maximum composite likelihood distances.
Multiple sequences of the same type are shown as triangles with heights proportional their numbers and depths corresponding
to their earliest diverging branch. Within HRV-B, phylogenetic clusters with pairwise p-distances ranging from 0.1900 to
0.2600 are indicated by grey-outlined boxes. Instances where two types have been combined to form a single type are
indicated in yellow. New HRV types defined on the basis of sequence divergence in VP1 are shown in red and HRV types with
VP1 intra- or inter-type divergence outside the proposed thresholds are shown in purple. Bars, 0.05 nt substitutions per site.
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bootstrap-supported monophyletic groups that closely
matched types assigned by sequence distances. These
groups were numbered either by clustering with a known
prototype strain (HRV-A/B 1–100), by order of submission
of full-genome (HRV-A101–106, HRV-B100–104 and
HRV-C1–11) or VP1 sequences (HRV-C12–51). The vast
majority of sequences within each terminal clade showed
intra-clade VP1 divergence substantially less than the
proposed thresholds of 13% in HRV-A and -C and 12%
in HRV-B (Table 1). Most of these also showed a minimum
inter-clade VP1 divergence (with a different assigned type)
that was much greater than the proposed threshold.
Identification of new types on the basis of
sequence divergence in VP1
Consistent with the thresholds identified for each species,
three new types of HRV-A and three of HRV-B have been
proposed previously; HRV-A101 (Rathe et al., 2010),
HRV-A102 (de Vries et al., 2008), HRV-A103, HRV-
B100 (Linsuwanon et al., 2011), HRV-B101 and HRV-B102
(McIntyre et al., 2013) (http://www.picornaviridae.com).
In addition, the current analysis provided evidence for
three further new HRV-A types (tentatively labelled HRV-
A104–A106) and two novel HRV-B types (HRV-B103 and
-B104), labelled in red in Fig. 2. The additional sequence
data provided in this study and published elsewhere for
HRV-C now create a phylogenetic tree that can be divided
into 51 distinct clades. These have been assigned as types
based on sequence divergence in the VP1 region (Table 1),
adding a further 18 types to the total of 33 first defined in 2010
(Simmonds et al., 2010) (http://www.picornaviridae.com).
Although several of the putative new HRV-A and -B types
included showed minimum VP1 distances far greater than
the assignment thresholds shown in Fig. 1, several were
close to or below the 13 and 12% levels (Table 1). As
examples of the former, proposed new HRV-B types B100,
B101 and B102 showed minimum pairwise p-distances in
VP1 of 0.214, 0.190 and 0.227 from their nearest confirmed
HRV-B type (HRV-B35). Pairwise nucleotide p-distances
between these three new HRV-B types ranged from 0.163
to 0.171. All proposed species C types were similarly clearly
above the assignment threshold of 13% for this species
(Table 1). However, other variants proposed as new types
showed minimum distances that were much closer to the
threshold; for example, the six available sequences from the
novel group putatively designated HRV-B103 showed VP1
distances from their nearest neighbour type (HRV-B6)
ranging from 0.113 to 0.148. However, for these two types,
only two pairwise comparisons fell below the 12%
threshold and both involved sequence F110_9318.
The newly designated HRV-B104 represented a division of
a previously single type, HRV-B52, based on the existence
of two discrete phylogenetic clades with VP1 p-distances of
0.121–0.142 between them. In this case, the clade contain-
ing the original ATCC isolates, including strains FJ445188
(GenBank accession no.) and EF173424, has retained the
HRV-B52 designation, whereas the clade containing field
isolates FJ445137 and JF781506 has been reassigned as
HRV-B104. Similar variability was observed in species A
where two of the proposed new types showed distances
close to the assignment threshold (HRV-A104 and -A105).
Reassignment of types with pairwise distances
below assignment thresholds
Analysis of pairwise VP1 divergence between previously
recognized HRV-A types also revealed several examples of
VP1 distances below the 13% threshold. For example,
HRV-A8 and HRV-A95 showed an inter-type VP1 p-
distance range of 0.015–0.019. We propose that all
sequences of these two types are reassigned as HRV-A8, a
proposal consistent with their previously documented
serological cross-reactivity (Ledford et al., 2004) (Fig. 3a).
Similarly, HRV-A29 and HRV-A44 have previously demon-
strated cross-reactivity (Cooney et al., 1982) and prototype
strains showed an inter-type VP1 p-distance of 0.0724 (Fig. 3a).
We propose that these sequences be reassigned as HRV-A29.
Interestingly, contemporary sequences that belonged to HRV-
A29 by VP1 p-distance from the prototype strains (maximum
p-distance of 0.127) showed a maximum divergence of 0.159
when compared with each other. All contemporary HRV-A29
sequences grouped separately on phylogenetic trees from both
the HRV-A29 and HRV-A44 prototype sequences (Fig. 3a).
HRV-A54 and HRV-A98 are a third type pair that are more
closely related than expected, with a pairwise nucleotide
VP1 p-distance of 0.107–0.124 (Fig. 3a). Although cross-
neutralization properties of these two types have not been
analysed in previous studies (Cooney et al., 1982; Ledford
et al., 2004), we propose that all variants classified as these
two types are reassigned as HRV-A54.
In addition to those type pairs that have been combined
into single type assignments, a number of other HRV types
displayed intermediate divergence values that violated the
proposed thresholds. These included HRV-A1A and -A1B,
which are serologically cross-reactive (Cooney et al., 1982)
but showed several pairwise p-distances that fell above the
VP1 threshold (Fig. 3). We propose that members of
these two clades retain their assignment as HRV-A1,
although this should be reviewed as more sequences and
confirmatory serological data become available. As a
contrasting problem, the type pair HRV-A25 and -A62
showed VP1 pairwise distances ranging from 0.093 to 0.103
from each other (Fig. 3b), below the assignment threshold,
despite showing no cross-neutralization (Cooney et al., 1982).
We propose leaving these assignments unchanged pending
confirmation of the serological relationship between these
two types. Similarly, prototype isolates of types HRV-A36 and
-A89 (GenBank accession nos DQ473508 and M162488)
showed VP1 p-distances of 0.1292, just below the assignment
threshold (Fig. 3b). For these types, the HRV-A36 antiserum
can neutralize HRV-A89 (as well as HRV-A50 and HRV-
A58). However, the antiserum to HRV-A89 cannot neutralize
Classification of rhinovirus species A, B and C
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Table 1. Limits of intra- and inter- clade VP1 p-distance for
HRV-A, -B and -C
New HRV types defined on the basis of sequence divergence in VP1
are indicated in bold.
Type Intra* InterD
A1 0.0906 0.1185
A1B 0.1092 0.1185
A2 0.1060 0.1407
A7 0.0046 0.1816
A8 0.0035 0.0153
A9 0.1085 0.1476
A10 0.0999 0.1701
A11 0.0000 0.1722
A12 0.0999 0.2625
A13 0.0816 0.1713
A15 0.1034 0.1638
A16 0.0889 0.1719
A18 0.0859 0.1754
A19 0.0977 0.2272
A20 0.0999 0.1504
A21 0.0952 0.2054
A22 0.1133 0.1903
A23 0.1072 0.1429
A24 0.0760 0.1310
A25 0.0059 0.0934
A28 0.1123 0.2280
A29d 0.0072 0.0724
A30 0.1107 0.1429
A31 0.1166 0.1404
A32 0.0012 0.1476
A33 0.1026 0.1608
A34 0.0964 0.1580
A36 0.1150 0.1200
A38 0.0943 0.1916
A39 0.0094 0.2340
A40 0.1214 0.1597
A41 0.0057 0.1713
A43 0.1096 0.1606
A44d 0.0072 0.0724
A45 0.0813 0.2521
A46 0.0057 0.2027
A47 0.1216 0.1404
A49 0.1001 0.1407
A50 0.0023 0.1580
A51 0.0991 0.1903
A53 0.1027 0.2220
A54 0.0872 0.1072
A55 0.0557 0.2066
A56 0.0000 0.2006
A57 0.0000 0.1285
A58 0.0862 0.1567
A59 0.0897 0.1362
A60 0.0977 0.1965
A61 0.1017 0.1804
A62 0.0071 0.0934
A63 0.0000 0.1737
A64 0.0058 0.1580
Table 1. cont.
Type Intra* InterD
A65 0.0653 0.1903
A66 0.0845 0.1302
A67 0.0946 0.1778
A68 0.1044 0.1504
A71 0.0045 0.1719
A73 0.0034 0.1822
A74 0.0058 0.1638
A75 0.0785 0.1606
A76 0.0921 0.1608
A77 0.0012 0.1852
A78 0.1162 0.2625
A80 0.0871 0.2027
A81 0.1298 0.1719
A82 0.1050 0.1951
A85 0.0058 0.1597
A88 0.0011 0.1816
A89 0.0879 0.1200
A90 0.0000 0.1743
A94 0.0000 0.1580
A95 0.0000 0.0153
A96 0.0000 0.1804
A98 0.0000 0.1072
A100 0.0000 0.1468
A101 0.0611 0.2608
A102 0.0000 0.1509
A103 0.0685 0.2162
A104 0.0000 0.1310
A105 0.0671 0.1285
A106 0.0000 0.1719
B3 0.0045 0.2176
B4 0.0938 0.1957
B5 0.0139 0.1667
B6 0.0881 0.1134
B14 0.0178 0.1862
B17 0.0068 0.1242
B26 0.0022 0.1863
B27 0.0034 0.1762
B35 0.0134 0.1910
B37 0.0782 0.1474
B42 0.0984 0.1667
B48 0.1101 0.1876
B52 0.0057 0.1209
B69 0.1017 0.1810
B70 0.1160 0.1242
B72 0.0992 0.1862
B79 0.0046 0.1924
B83 0.0884 0.1695
B84 0.1013 0.2226
B86 0.1048 0.2184
B91 0.0846 0.1427
B92 0.0046 0.1695
B93 0.0024 0.1762
B97 0.0035 0.1937
B99 0.0012 0.1817
B100 0.0000 0.1655
B101 0.0157 0.1627
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HRV-A36 and almost all pairwise distances between more
recent isolates of HRV-A36 (n59) and HRV-A89 (n55) are
above the assignment threshold. We propose to retain their
current designations as HRV-A36 and HRV-A89.
Only one HRV-C type showed p-distance values that violated
proposed thresholds. HRV-C8 strains were divided into two
clades, one previously classified as HRV-Cpat28 and both con-
taining contemporary sequences (Fig. 3b). Although the VP1
p-distance between the two clades ranged from 0.129 to 0.132,
we propose that these two clades should remain classified as
HRV-C8 on the basis of borderline VP1 divergence.
Despite these examples, the number of pairwise distances
in the overall distribution that were close to the assignment
threshold (and therefore potentially ambiguously assigned)
was small (Fig. 4). The majority represented comparisons
between type pairs that should be combined (Fig. 4, green).
Only six HRV-A types showed any between-type distances
that were below the threshold (pink), and there were three
with within-type distances that were above (Fig. 4, purple).
As described above, their current classification can
incorporate phylogenetic data and any available informa-
tion on neutralization properties in addition to VP1
distances. Combined, these may potentially resolve any
remaining uncertainties over type assignments.
At the conclusion of this analysis of all available HRV VP1
sequences, totals of 77 HRV-A types, 29 HRV-B and 51
HRV-C types have been listed in full in Tables S1 and S2).
Novel strains of HRV were classified based on date of
submission to the Picornaviridae Study Group, rather than
the earliest isolated strain.
HRV classification using VP4/2 sequences
The well-conserved and readily amplified VP4/VP2 region
of HRV is commonly used in studies of its epidemiology
and clinical associations, with over 3900 HRV sequences
from this region in GenBank, over 10 times the number of
VP1 sequences (n5384). To investigate the value of VP4/
VP2 sequences for HRV type identification, we performed
phylogenetic analysis on the entire dataset and compared
groupings of sequences of known type to those observed in
VP1 (Fig. 5).
The majority of HRV strains grouped congruently between
VP1 and VP4/VP2. Only one sequence showed evidence
of phylogenetic incongruence; JX291115 is a member
of HRV-C51 type in the VP1 region, with a pairwise
nucleotide p-distance of 0.01 to JF317015 (HRV-C51
Table 1. cont.
Type Intra* InterD
B102 0.0000 0.1627
B103 0.0351 0.1134
B104 0.0845 0.1209
C1 0.0515 0.2293
C2 0.0569 0.1650
C3 0.0388 0.1460
C4 0.0158 0.1394
C5 0.0421 0.1704
C6 0.0663 0.1460
C7 0.0751 0.1516
C8 0.1315 0.2196
C9 0.1103 0.2818
C10 0.0368 0.2049
C11 0.0000 0.1704
C12 0.1007 0.1965
C13 0.0045 0.2640
C14 0.0000 0.2147
C15 0.0917 0.2714
C16 0.0440 0.1473
C17 0.0175 0.1473
C18 0.0527 0.1925
C19 0.0724 0.3017
C20 0.0073 0.1510
C21 0.0098 0.1516
C22 0.0368 0.2500
C23 0.0813 0.2699
C24 0.0000 0.2274
C25 0.1088 0.2274
C26 0.0394 0.2611
C27 0.0308 0.2239
C28 0.0348 0.1925
C29 0.0000 0.2390
C30 0.0000 0.1842
C31 0.0000 0.2196
C32 0.0282 0.1357
C33 0.0209 0.1890
C34 0.0266 0.1510
C35 0.0000 0.3263
C36 0.1111 0.2564
C37 0.0000 0.2069
C38 0.0344 0.1735
C39 0.0257 0.1357
C40 0.0702 0.1650
C41 0.0748 0.1842
C42 0.0856 0.2407
C43 0.1157 0.2466
C44 0.0000 0.1965
C45 0.0428 0.2390
C46 0.0000 0.2564
C47 0.0000 0.2217
C48 0.0000 0.1890
C49 0.0311 0.1394
C50 0.0000 0.2859
C51 0.0049 0.2069
*Maximum VP1 p-distance observed within a bootstrap-supported
phylogenetic clade or putative type.
DMinimum VP1 p-distance observed between one particular boot-
strap-supported phylogenetic clade and its nearest neighbour.
dIn cases where contemporary strains group separately from
prototype strains of two types, which should potentially be combined
(A29/A44), the p-distance listed involves the prototype strains only.
Table 1. cont.
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prototype strain). However, in VP4/VP2, this sequence
showed a VP1 p-distance of 0.146 from JF317015 and lay
closest to HRV-C15. Its status as a recombinant sequence
was demonstrated by triplet analysis using the RDP software
package. In contrast, comparable analysis of all other
HRV-C and HRV-A/B variants with both full VP4/2 and
VP1 sequences available by RDP and GARD (164 types in
species A, 70 in species B and 145 in species C)
demonstrated no evidence of recombination between
regions.
We previously proposed a divergence threshold of 10%
for identifying different HRV-C types using VP4/VP2
sequences (Simmonds et al., 2010). Using the current
much larger dataset of HRV-C sequences and a shorter
fragment (positions 616–1004, based on typical coordi-
nates of sequences available in GenBank), pairwise p-
distance distributions were plotted, along with those for
species A and B (Fig. 6). Detailed inspection of distribu-
tions of pairwise distances showed possible assignment
thresholds of 10.5, 9.5 and 10.5% for HRV-A, -B and -C,
respectively, based on minimum values. The shorter length
and greater sequence conservation than VP1 resulted in
less-well-defined thresholds and a greater proportion of
pairwise comparisons close to the assignment threshold,
which may cause problems with type identification.
For example, four type pairs showed VP4/VP2 divergence
that was below the proposed threshold [HRV-A31/A47
(0.083), HRV-B52/B104 (0.093), HRV-C4/C49 (0.100) and
HRV-C32/C39 (0.090)] even though they were previously
assigned as different types based on VP1 divergence and
separate clustering by phylogenetic analysis (Table 1 and
Fig. 2). More problematic was the larger number of HRV
variants of the same type with VP4/VP2 divergence above
the assigned thresholds (22, 10 and six types of HRV-A,
0.05
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(a) HRV-A types to be combined
(b) HRV ‘intermediate’ types
Fig. 3. Neighbour-joining phylogenetic trees of HRV-A type pairs that do not conform to the proposed VP1 divergence
thresholds. Sequences of previously recognized prototype isolates of each HRV type are highlighted in bold and italic. (a) Three
HRV-A type pairs that have been combined. (b) Four HRV type pairs that displayed intermediate divergence values are shown.
Bars, 0.05 nt substitutions per site.
C. L. McIntyre, N. J. Knowles and P. Simmonds
1798 Journal of General Virology 94
-B and -C, respectively; Table S3). Most of these types
contained several contemporary sequences that had
diversified substantially from their corresponding pro-
totype sequence. In these cases, p-distances above the
threshold occurred between contemporary isolates diver-
sifying on separate evolutionary lineages, while retaining
similarity in the intra-type range with their corresponding
prototype type strain [VP4/VP2 distances of ,10.5%
(species A) or 9.5% (species B)]. This is similar to the
pattern observed within the VP1 region of contemporary
strains of HRV-A29.
Using VP4/VP2 sequences for assignment of
provisionally assigned types (PATs)
The original HRV-C classification included 28 PATs, which
were temporarily assigned on the basis of VP4/VP2
sequence divergence alone (Simmonds et al., 2010) until
a matching VP1 sequence was obtained. Of these original
28 PATS, 16 have since been reassigned as new (confirmed)
types based on VP1 divergence (new HRV-C type
designations listed in Table S1 and S2), whilst one was
combined into an existing type (HRV-C8/Cpat28; see
above). VP1 sequences are unavailable for the remaining 11
PATs (Table S4).
Eight further divergent VP4/VP2 groups were identified
among species A (n54), and species B (n54) (Table S4). A
further three provisionally assigned HRV-C types were also
detected (designated HRV-Cpat29-pat31). All showed
divergence above the VP4/VP2 threshold proposed for
their species. These await sequence data from VP1 to
confirm their assignment as different types.
Geographical distribution of HRV types
The distribution of HRV types (identified using the larger
dataset of VP4/VP2 sequences and excluding PATs) was
compared for the UK, the rest of Europe, the USA, Asia
and other regions (Australia, the Middle East and Africa).
Each geographical zone contained similar relative frequen-
cies of HRV-A, -B and -C (Fig. 7). Individual types showed
considerable variability in detection frequency, although
those that were common showed similar detection
frequencies in different geographical areas. Similarly, none
of the prevalent HRV types showed any geographical
restriction, findings that suggest that most or all HRV types
circulate freely worldwide.
DISCUSSION
Genotypic identification of HRV species and types
The ability to perform genotyping directly from clinical
specimens removes the need for cell culture passage and
therefore greatly reduces the time required for type
identification for all three HRV species. It additionally
allows variants refractory to virus isolation, such as species
C, to be identified. This parallels the transition from
isolation and neutralization assay to VP1 sequencing for
the identification of EV (sero)types (McWilliam Leitch
et al., 2009; Mirand et al., 2009; Nix et al., 2006). Because of
its shorter length, greater sequence conservation and the
possibility of using the same set of primers for amplifica-
tion of all three HRV species, the VP4/VP2 region has been
most commonly used for genetic characterization of HRV
in clinical samples (Blomqvist et al., 2009; Han et al., 2009;
Mizuta et al., 2010; Savolainen-Kopra et al., 2009; Wisdom
et al., 2009a). Comparison of its predictive value compared
with type assignments based on VP1 sequences provides
evidence for its suitability of HRV type identification along
with some restrictions. The latter include uncertainties in
type identifications of variants showing sequence diver-
gences from other HRV sequences close to the threshold
assigned to that species. Examples of both inter-type
distances below this threshold and intra-type distances
above have been presented (Table S3), although patterns of
phylogenetic clustering of variants provide further con-
tributory information for type identification.
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Overall, however, the thresholds we have proposed divide
HRV sequences into groups that correspond most
consistently with phylogenetic groupings (with the small
number of exceptions we have specifically itemised).
Placing thresholds in any other position in the distance
distributions would create groupings that conflict with
those defined by phylogenetic analysis and by serology
relationships. Placing the threshold at a minimum point in
the distribution additionally minimizes the number of
conflicting between- and within-group distances within an
assigned type.
The identification and definition of HRV types by using
genetic data within the capsid region has the potential to
revolutionize HRV typing. The ease with which this can be
carried out, compared with traditional virus culture and
neutralization assays, should make the endeavour of
classifying all detected HRV sequences much more feasible
and attractive. A more extensive global or sentinel system of
type identification should allow large-scale investigations of
HRV epidemiology, transmission and evolution; sequence
data for comparisons are available worldwide almost instantly
and will be of considerable value in surveillance for the
emergence of new types of species with differing clinical
presentations from those traditionally attributed to HRV.
Proposed criteria for the division of HRV into
genotypically assigned types
In addition to type identification, the definition of robust
nucleotide divergence thresholds for the definition of new
EV types (25%) now provides the primary means for the
assignment of new EV types (Oberste et al., 1999a, b). This
has been used for several years and has created the
assignment of 36 new EV types numbered from EV-73
onwards (Brown et al., 2009; Norder et al., 2003; Oberste
et al., 2004, 2007; Smura et al., 2007a, b; Tapparel et al.,
2009; Yozwiak et al., 2010). We propose an equivalent
system for the assignment of new HRV types in which
criteria similar to those proposed for the assignment of
species C rhinoviruses (Simmonds et al., 2010) are
extended to HRV-A and -B. HRV does, however,
differ from EVs in showing lower divergence thresholds
for type assignments (12–13% nucleotide sequence
divergence in VP1) and a lack of capsid recombination
that enables VP4/VP2 sequences to be used at least for type
identification. The criteria for HRV have been formulated
as follows:
1. An HRV type should be phylogenetically distinct
from other HRV types.
2. Analysis of divergence in the VP1 region should
include at least 90% of the full VP1 coding region
for each variant.
3. In the VP1 region, an HRV type should have at least
13% (HRV-A), 12% (HRV-B) or 13% (HRV-C)
nucleotide divergence from all other HRV types.
4. In cases where minimum nucleotide divergence in
VP1 of a putative new type lies close to the threshold
for that species (±1%), patterns of phylogenetic
grouping with existing types may contribute to its
assignment as would any available information on
serological cross-reactivity.
5. VP4/VP2 sequences are predictive of HRV species
and type and can be used for type identification in
epidemiological studies.
6. HRV variants divergent from all known VP4/VP2
sequences (i.e. above type-assignment thresholds for
the identified species in this region) but without an
available VP1 sequence may be designated a PAT.
7. Subsequent determination of VP1 sequences for
PATs would allow their reassignment as new types if
they show VP1 sequence divergence above the thresh
old for that species).
8. New HRV type names should be numbered
sequentially and separately for each species – the
next assignments for the three rhinovirus species
would be HRV-A107, HRV-B105 and HRV-C52.
9. The ‘prototype strain’ of each new HRV type should
be the first reported full-genome sequence or, if this
is unavailable, the first reported full VP1 sequence.
10. The Picornaviridae Study Group should continue to
oversee assignment of new HRV types, as the group
includes members with specific expertise in EV type
assignment and a number of scientists currently
active in HRV research.
The use of only capsid-coding regions in type-assignment
criteria should not detract from the importance of
continued investigation of other genomic regions, in
particular where these may contribute to the phenotype
and disease associations of HRV. In addition, the use of the
VP1 region for definition of new HRV types should not
discourage the widespread continued use of 59-untrans-
lated region and VP4/VP2 screening protocols. Screening
with these relatively conserved regions allows a much
greater opportunity for discovery of previously unknown
HRV types through further sequence characterization of
VP1 and other genome regions. Although this represents,
to our knowledge, the most comprehensive survey of HRV
sequence data currently possible, the guidelines should
be subject to further review as additional data becomes
available.
In all three species, the phylogeny of the full VP1 region
reliably separated isolates of known differing type into
distinct bootstrap-supported clades. This is consistent with
the presence of a large number of the neutralizing
immunogenic sites in HRV-A and -B (Kistler et al.,
2007b) that underlie their serological properties. The
difficulties with culturing species C rhinoviruses have to
date prevented their serological properties from being
directly investigated. It is possible that the sinus mucosal
Classification of rhinovirus species A, B and C
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organ culture system used to culture HRV-C15 might
prove more broadly applicable for other species C variants
(Bochkov et al., 2011). Limited serological reinvestigation
of a number of previous HRV-A and -B type assignments
would be useful for isolates where cross-reactivity is
uncertain (such as HRV-A54/A98) or conflicts with their
sequence divergence in VP1.
There is a possibility that a smaller fragment of VP1 could
be suitable for genotyping in HRV. Oberste et al. (1999b)
reported that a 450 nt segment at the 39 end of VP1 was
effective for EV type identification and the results had a
100% correlation with neutralization results. A second
study showed full correlation of a 303 nt stretch of VP1
with neutralization data, but this was only applied to 59
strains (Kiang et al., 2009). In addition, a simple, fast and
effective method of typing EVs by pyrosequencing has
recently been developed (Silva et al., 2008). This may
become extremely useful as pyrosequencing becomes more
widely available worldwide. Whether a shorter region than
the whole VP1 would be similarly predictive of HRV types
and could be used for future type assignments requires
further investigation.
METHODS
Selection of samples. VP4/VP2 sequences generated from several
studies of HRV molecular epidemiology in the UK (Gaunt et al.,
2011; Harvala et al., 2012; McIntyre et al., 2010, 2013; Simmonds et al.,
2010; Wisdom et al., 2009a, b) (Simmonds et al., unpublished data)
(431 HRV-A and 113 HRV-B) were divided into groups based on
phylogenetic clustering. Any isolate that did not show a close
grouping with a prototype full genome or represented a distinct
phylogenetic cluster of HRV-C was selected for amplification of the
VP1 region. The procedure for amplification of the VP1 region of
HRV-A, -B and -C and initial descriptions of sequences generated
have been described previously (McIntyre et al., 2010, 2013;
Simmonds et al., 2010).
Sequence alignment, calculation of pairwise nucleotide p-
distances and phylogenetic analysis. All available HRV VP4/VP2
and VP1 sequences were downloaded from GenBank in November
2012. The genome regions analysed in this study included the full VP1
region and a fragment of VP4/VP2 (nt 616–1004 numbered according
to GenBank accession no. EF582385 for HRV-C4) that is commonly
used in studies of HRV epidemiology (Blomqvist et al., 2009; Han
et al., 2009; Henquell et al., 2012; Kaida et al., 2011; Miller et al., 2009;
Mizuta et al., 2010). Any sequences that were ,90% complete across
these regions or wereclassified as non-functional were excluded. All
sequences were aligned using the SSE v1.0 sequence editor package
(Simmonds, 2012) and pairwise nucleotide p-distances were calcu-
lated using the program Sequence Distances within the package.
Phylogenetic trees were constructed in the MEGA v5.0 software
package (Tamura et al., 2011) by the neighbour-joining method
(Saitou & Nei, 1987) from 100 bootstrap resampled sequence
alignments of maximum composite likelihood (Guindon & Gascuel,
2003) distances, with pairwise deletion for missing data. All
phylogenetic analysis was undertaken using the Enterovirus D sequence
(GenBank accession no. D00820 for EV-D70) as an outgroup.
Analysis of recombination within the capsid region of HRV-A,
-B and -C. Phylogenetic trees were inspected visually for evidence
of incongruence between the VP4/VP2 and VP1 regions. Datasets
containing these two non-consecutive regions were concatenated to
give one continuous sequence, which was then additionally analysed
for the occurrence of recombination. RDP v4.0 (Martin et al., 2010)
analysis was used to screen each HRV species dataset for the
occurrence of recombination within the capsid-coding region. Each
sequence set was examined using a combination of algorithms
implemented in the software package, specifically RDP (Martin &
Rybicki, 2000), GeneConv (Padidam et al., 1999), MaxChi (Smith,
1992), Chimaera (Posada & Crandall, 2001), SiScan (Gibbs et al.,
2000) and Bootscan (Martin et al., 2005). A threshold P value of
,0.05 and detection by at least two algorithms was required for a
recombination event to be detected. Each HRV species dataset was
further analysed using the GARD program (Kosakovsky Pond et al.,
2006) as part of the HyPhy package. Any predicted recombination
breakpoints were analysed by construction of neighbour-joining
maximum composite likelihood trees for sequence fragments 59 and
39 to the putative breakpoint.
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